PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
12-Jun-2023 UPLIZNA® (inebilizumab-cdon) Pivotal Trial Publication Integrating MRI and Biomarker Evaluation Shows Accuracy and Uniformity of Attack Diagnoses for Neuromyelitis Optica Spectrum Disorder (NMOSD) Businesswire
12-Jun-2023 Charles River and Curigin Collaborate to Produce Oncolytic RNAi Gene Therapy Businesswire
12-Jun-2023 Model N Named One of Fortune's 2023 Best Workplaces in the Bay Area Businesswire
12-Jun-2023 PharmaLink Announces Acquisition of PharmaReturns Newswire
12-Jun-2023 Coya Therapeutics’ CEO Dr. Howard Berman’s Letter to Stockholders Businesswire
12-Jun-2023 Simcere Pharmaceutical Group Announces Sponsored Research Agreement with Boston-based Mass General Brigham Businesswire
12-Jun-2023 Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara® Businesswire
12-Jun-2023 Catalent, Inc. Reports Third Quarter Fiscal 2023 Results Businesswire
12-Jun-2023 Merck to Present Data for Efinopegdutide (MK-6024), an Investigational GLP-1/Glucagon Receptor Co-agonist, in Patients with Nonalcoholic Fatty Liver Disease (NAFLD) at EASL 2023 Businesswire
12-Jun-2023 KalVista Pharmaceuticals Presents New Data at 2023 Meeting of the European Academy of Allergy and Clinical Immunology Businesswire
12-Jun-2023 Applied BioCode Announces the Launch of the Fungal Panel Assay for Research Use Businesswire
12-Jun-2023 Veristat Acquires European Medical Writing Consultancy Scinopsis Businesswire
12-Jun-2023 Digital Therapeutics Alliance and Healthware Group Launched First DTx Policy Report and Website Dedicated to Helping Advance Equitable Access and Adoption of Safe and Effective DTx and Digital Medical Devices Businesswire
12-Jun-2023 US FDA Grants for Over-the-Counter Marketing Authorization to Futura for Fast-Acting Topical Gel, MED3000, to Treat Erectile Dysfunction Businesswire
12-Jun-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
12-Jun-2023 Innate Pharma to Present Updated Interim Phase 2 Efficacy Results of Lacutamab in Mycosis Fungoides at the International Conference on Malignant Lymphoma Businesswire
10-Jun-2023 Innate Pharma Highlights Proprietary Tetra-specific ANKET® NK Cell Engager IPH6501 at the EHA 2023 Congress Businesswire
09-Jun-2023 Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Businesswire
09-Jun-2023 MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital Businesswire
09-Jun-2023 Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of May 31st, 2023 Businesswire